Markets:

Overview

News

Currencies

International

Treasuries

Inovio Pharmaceuticals, Inc. - Common Stock (NQ:INO)

1.535 -0.055 (-3.46%)

Streaming Delayed Price Updated: 11:08 AM EST, Jan 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Inovio Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Looking Into Inovio Pharmaceuticals's Return On Capital Employed ↗

September 16, 2021

Inovio Pharmaceuticals (NASDAQ:INO) brought in sales totaling $272.82 thousand during Q2 according to data provided by Benzinga Pro. However, earnings decreased 58.32%, resulting...

Via Benzinga

Etsy And NetApp Lead The S&P 500 ↗

August 26, 2021

U.S. indices were trading lower Thursday as traders await signs of Fed tapering policy. Explosions outside of Kabul airport in Afghanistan has also caused macro uncertainty and...

Via Benzinga

Topics Economy Stocks

Why Inovio Stock Is Jumping Today ↗

August 26, 2021

The vaccine maker received some good news from Brazil.

Via The Motley Fool

Inovio Pharmaceuticals Stock Nears End Of Technical Pattern ↗

August 26, 2021

Inovio Pharmaceuticals Inc. (NASDAQ:INO) shares are trading...

Via Benzinga

Inovio To Start Global Late-Stage COVID-19 Vaccine Trial ↗

August 26, 2021

The regulatory authority of Brazil has signed off Inovio Pharmaceuticals Inc's (NASDAQ: INO) global Phase 3 segment of its INNOVATE Phase 2/3 trial for INO-...

Via Benzinga

Analyzing Inovio Pharmaceuticals's Unusual Options Activity ↗

August 09, 2021

Inovio Pharmaceuticals (NASDAQ:INO) shares experienced unus...

Via Benzinga

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight ↗

August 08, 2021

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...

Via Benzinga

Why Inovio's Stock Is Trading Higher Today ↗

August 26, 2021

Inovio Pharmaceuticals Inc (NASDAQ: INO) is trading higher Thursday after the company announced it received regulatory authorization from Brazil's ANVISA to initiate the...

Via Benzinga

August 25, 2021

Not every stock on the popular trading app is worth owning.

Via The Motley Fool

Why Dynavax, Novavax, and Inovio Stocks Sank This Week ↗

August 20, 2021

Investors appeared to be rattled by the U.S. government's decision to move forward with booster doses of mRNA vaccines.

Via The Motley Fool

Unusual Options Activity Insight: Inovio Pharmaceuticals ↗

August 18, 2021

On Wednesday, shares of Inovio Pharmaceuticals (NASDAQ:INO) saw unusual options activity. After the option alert, the stock price moved down to $8.29. Sentiment: BULLISH Option...

Via Benzinga

3 Scary COVID Stocks to Avoid ↗

August 17, 2021

Our Fool roundtable picks three COVID stocks they think are dangerous at these prices.

Via The Motley Fool

77 Biggest Movers From Yesterday ↗

August 13, 2021

Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) shares surged 65.4% to close at $2.10 on Thursday after the company announced it is expanding its blockchain business to...

Via Benzinga

Apple And Salesforce Lead The DIA In A Mixed Day Of Trading ↗

August 12, 2021

U.S. indices had a mixed day of trading Thursday as traders and investors weigh COVID-19 variant updates, recent earnings and the recently passed $1 trillion...

Via Benzinga

Watch Out: Inovio Pharmaceuticals Is Heating Up ↗

August 12, 2021

Inovio Pharmaceuticals Inc. (NASDAQ: INO) shares are trading higher Thursday alongside other vaccine maker stocks. Stocks have been trading higher recently as the COVIS-19 delta...

Via Benzinga

85 Biggest Movers From Yesterday ↗

August 11, 2021

Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) jumped 125.3% to close at $18.77 on Tuesday after the company announced positive interim results from the Phase 1 trial with FTX...

Via Benzinga

Why Inovio Pharmaceuticals Is Plunging Today ↗

August 10, 2021

Solid business developments did not please investors.

Via The Motley Fool

Why Inovio's Stock Is Trading Lower Today ↗

August 10, 2021

Inovio Pharmaceuticals Inc (NASDAQ: INO) shares are trading lower by 9.9% at $8.65 after the company reported worse-than-expected second-quarter EPS and sales results....

Via Benzinga

54 Stocks Moving In Tuesday's Mid-Day Session ↗

August 10, 2021

Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) climbed 79.3% to $14.93 after the company announced positive interim results from the Phase 1 trial with FTX-6058 in healthy...

Via Benzinga

Inovio Pharmaceuticals (INO) Q2 2021 Earnings Call Transcript ↗

August 10, 2021

INO earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Recap: Inovio Pharmaceuticals Q2 Earnings ↗

August 09, 2021

Shares of Inovio Pharmaceuticals (NASDAQ:INO) moved lower in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share were down 95.00% year...

Via Benzinga

Why Inovio Stock Is Jumping Today ↗

August 09, 2021

Chinese regulators approved the initiation of two new clinical studies featuring Inovio's COVID-19 vaccine candidate, INO-4800.

Via The Motley Fool

What Does the Delta Variant Mean for Inovio Pharmaceuticals' Stock? ↗

August 05, 2021

Its vaccine candidate might be too far behind to matter.

Via The Motley Fool

Is Inovio Pharmaceuticals Primed For a Comeback? ↗

July 22, 2021

The past 12 months have been tough on the vaccine maker.

Via The Motley Fool

Here's Why Inovio Pharmaceuticals Soared 23% In June ↗

July 08, 2021

Encouraging news reversed what had been a steep sell-off for the clinical-stage biotech.

Via The Motley Fool

Earnings Scheduled For August 9, 2021 ↗

August 09, 2021

Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of $215.17 million. •...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 24, 2021 ↗

June 24, 2021

Upgrades Zelman upgraded the previous rating for Armstrong World Industries Inc (NYSE:

Via Benzinga

Inovio Pharmaceuticals: Return On Capital Employed Insights ↗

June 24, 2021

During Q1, Inovio Pharmaceuticals's (NASDAQ:INO) reported sales totaled $371.12 thousand. Despite a 79.13% in earnings, the company posted a loss of $52.55 million. In Q4, Inovio...

Via Benzinga

Inovio Pharmaceuticals Could See a Boost from Covid-19 Partnerships ↗

June 21, 2021

Some say INO stock could be the target of a short squeeze, but Inovio's Covid-19 vaccine program should be a sufficient reason to invest.

Via InvestorPlace

Should You Buy Biotech ETFs Now? ↗

June 16, 2021

Instead of trying to pick winners in this volatile space, it is better to invest in broader biotech ETFs that stand to benefit from increased investor interest and rising spending on drugs and...

Via Talk Markets

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Inovio Pharmaceuticals, Inc. - Common Stock (NQ:INO)

All News about Inovio Pharmaceuticals, Inc. - Common Stock

Resources